Literature DB >> 19427026

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Kimberly A Lowe1, M Robyn Andersen, Nicole Urban, Pamela Paley, Charles W Dresher, Barbara A Goff.   

Abstract

OBJECTIVE: To evaluate the temporal stability of self-reported symptoms known to be associated with ovarian cancer.
METHODS: This report is a longitudinal analysis of symptom reporting from 123 women who participated in the Seattle-based Ovarian Cancer Early Detection Study (OCEDS). The OCEDS population includes women at increased risk of ovarian cancer based on a family history of cancer or a BRCA I/II mutation. Data on symptoms were collected at two time points using a Symptoms Index that included abdominal pain, pelvic pain, feeling full quickly, inability to eat normally, abdominal bloating, and increased abdominal size.
RESULTS: There was a median of 101 days between the two time points, with a range of 72-332 days. The median age of the women was 51, with a range of 32-79 years. Abdominal bloating was the most commonly reported symptom at both time points. The symptom least commonly reported at the two time points was inability to eat normally. The Symptoms Index was negative at both time points for 86% of all women and positive at both time points for 2% of all women. There were no statistically significant patterns of change for symptom reporting between time points.
CONCLUSIONS: The Symptoms Index and women's report of abdominal pain, pelvic pain, feeling full quickly, unable to eat normally, abdominal bloating, increased abdominal size were stable between two time points in this sample. These findings provide evidence that longitudinal measurements of symptoms reporting by women in a screening study are likely to be reliable.

Entities:  

Mesh:

Year:  2009        PMID: 19427026      PMCID: PMC2736546          DOI: 10.1016/j.ygyno.2009.03.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  18 in total

1.  A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker.

Authors:  Martin W McIntosh; Nicole Urban
Journal:  Biostatistics       Date:  2003-01       Impact factor: 5.899

2.  Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.

Authors:  M F Vine; R B Ness; B Calingaert; J M Schildkraut; A Berchuck
Journal:  Gynecol Oncol       Date:  2001-12       Impact factor: 5.482

3.  Symptoms of ovarian cancer.

Authors:  S H Olson; L Mignone; C Nakraseive; T A Caputo; R R Barakat; S Harlap
Journal:  Obstet Gynecol       Date:  2001-08       Impact factor: 7.661

Review 4.  Ovarian cancer: epidemiology, biology, and prognostic factors.

Authors:  C H Holschneider; J S Berek
Journal:  Semin Surg Oncol       Date:  2000 Jul-Aug

5.  Generating longitudinal screening algorithms using novel biomarkers for disease.

Authors:  Martin W McIntosh; Nicole Urban; Beth Karlan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-02       Impact factor: 4.254

6.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Authors:  Kimberly A Lowe; Chirag Shah; Erin Wallace; Garnet Anderson; Pamela Paley; Martin McIntosh; M Robyn Andersen; Nathalie Scholler; Lindsay Bergan; Jason Thorpe; Nicole Urban; Charles W Drescher
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  Ovarian cancer: early symptom patterns.

Authors:  Dixie Koldjeski; Mary K Kirkpatrick; Melvin Swanson; Lou Everett; Sylvia Brown
Journal:  Oncol Nurs Forum       Date:  2003 Nov-Dec       Impact factor: 2.172

8.  Frequency of symptoms of ovarian cancer in women presenting to primary care clinics.

Authors:  Barbara A Goff; Lynn S Mandel; Cindy H Melancon; Howard G Muntz
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

Review 9.  Ovarian cancer screening.

Authors:  Nicole Urban; Martin W McIntosh; Marin Andersen; Beth Y Karlan
Journal:  Hematol Oncol Clin North Am       Date:  2003-08       Impact factor: 3.722

10.  Symptoms and diagnostic difficulties in ovarian epithelial cancer.

Authors:  C Wikborn; F Pettersson; C Silfverswärd; P J Moberg
Journal:  Int J Gynaecol Obstet       Date:  1993-09       Impact factor: 3.561

View more
  3 in total

1.  Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Authors:  Barbara A Goff; Kimberly A Lowe; Jeannette C Kane; Marissa D Robertson; Marcia A Gaul; M Robyn Andersen
Journal:  Gynecol Oncol       Date:  2011-11-06       Impact factor: 5.482

2.  The detection, treatment, and biology of epithelial ovarian cancer.

Authors:  Jennifer Aa Gubbels; Nick Claussen; Arvinder K Kapur; Joseph P Connor; Manish S Patankar
Journal:  J Ovarian Res       Date:  2010-03-29       Impact factor: 4.234

Review 3.  Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer.

Authors:  Dmitri Pchejetski; Albandri Alfraidi; Keith Sacco; Heba Alshaker; Aun Muhammad; Leonardo Monzon
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-11       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.